True purpose-driven branding may not show dramatic results immediately, but you’ll soon see its impact if purpose permeates ...

Busch InBev's Q2 2025 earnings call, including EBITDA growth, premium brand performance, and digital expansion insights.

Unum Group's Q2 2025 earnings call highlights premium growth, adjusted EPS guidance of $8.50, LTC risk reduction, and strategic capital deployment.

The majority of Teva's business lies in generic and off-patent branded drugs which faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...